The largest database of trusted experimental protocols

8 protocols using cd34 pe

1

Chondrocyte Immunophenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chondrocytes (1×106) from growth plate (passage 1) were washed in PBS and incubated with corresponding primary antibodies for one hour at 4°C. Primary antibodies used here were conjugated antibodies specific for CD44-FITC (dilution 1:100, #550974; BD Biosciences, San Diego, CA, USA), CD29-PE (dilution 1:80, #48-0291; eBiosciences; Thermo Fisher Scientific, Inc.), CD34-PE (dilution 1:100; #sc-74499 PE; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), CD45-PE (dilution 1:80, #12-0461; eBiosciences; Thermo Fisher Scientific, Inc.) and unconjugated antibodies for CD105 (dilution 1:100, #ab11414) and CD146 (dilution 1:80, #ab75769) (both from Abcam, Cambridge, MA, USA). After washing with PBS, cells stained with CD105 and CD146 were incubated with anti-mouse FITC-conjugated secondary antibody (dilution 1:500, #A0568; Beyotime Institute of Biotechnology, Guangzhou, China) or Alexa Fluor 594 donkey anti-rabbit IgG (dilution 1:500, #A-21207; Invitrogen; Life Technologies) for 30 min at 4°C. The cells were washed twice and then re-suspended in 200 µl PBS for the flow cytometry analysis (FACSort; BD Biosciences).
+ Open protocol
+ Expand
2

Flow Cytometric Analysis of ASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fourth passage ASCs were cultured in complete media until sub-confluent prior to flow cytometric analysis (Becton Dickinson FACSCanto cytometer, Franklin Lakes, NJ). Media was removed by washing the ASCs with PBS. The ASCs were then harvested with 0.25% trypsin/EDTA. Cell viability was assessed via propidium iodide staining. Determination of fluorescent cells, dead cells, debris, and background noise was made with FACS DIVA software (Becton Dickinson, Franklin Lakes, NJ). For extracellular staining, the cells were treated with a mixture of ice-cold 1% sodium azide for 30 min, washed with PBS, and incubated with 3% bovine serum albumin (BSA) for 30 min on ice. Following a PBS wash, aliquots of ASCs were incubated in BSA with the following monoclonal antibodies for flow cytometry: CD73-Alexa 488 (BD Biosciences, San Jose, CA), CD90-Alexa 488 (BioLegend, San Diego, CA), CD11b-Alexa 488 (BioLegend, San Diego, CA), CD34-PE (Santa Cruz Biotechnology, Dallas, TX), CD36-Alexa 488 (BioLegend, San Diego, CA), and CD29-PECy7 (BioLegend, San Diego, CA). For intracellular staining, cells were counted and fixed with 4% paraformaldehyde for 20 min at room temperature, washed three times with PBS, and lysed with 90% ice-cold methanol for 30 min. The lysed cells were incubated in 3% BSA for 30 min and treated with a monoclonal primary antibody to CD105-PE (Bioss Inc., Woburn, MA).
+ Open protocol
+ Expand
3

Flow Cytometry Analysis of Rat Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells at passage three were digested, washed with PBS and incubated with antibodies against rat CD31-PE (BD Biosciences, New Jersey, USA), CD34-PE (Santa Cruz, Dallas, USA), CD45-FITC (BD Biosciences, New Jersey, USA), and CD90-PE (BD Biosciences, New Jersey, USA), as well as with isotype IgG1-PE (BD Biosciences, New Jersey, USA) and isotype IgG1-FITC (BD Biosciences, New Jersey, USA) for 30 min. Cells were then washed and centrifuged at 1500 rpm for 5 min. Finally, cells (5×105/ml) were suspended in PBS and analyzed by flow cytometry.
+ Open protocol
+ Expand
4

Isolation and Characterization of Rat BMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male Sprague–Dawley (SD) rats (Guangdong Medical Laboratory Animal Center, Foshan, Guangdong, China) weighing 50–60 g were sacrificed by cervical dislocation. The tibias and femurs were removed and washed with phosphate buffer saline (PBS) 3 times, and the bone marrow was extracted by syringe needles. The freshly isolated cells were cultured with Dulbecco’s modified Eagle’s medium (DMEM)/F12 cell culture medium (Life Technologies, USA) supplemented with 10% foetal bovine serum (FBS) and 100 U/ml gentamycin. Twenty-four hours later, the culture medium was replaced.
At passage 3, digested BMSCs were incubated with fluorescence-conjugated antibodies, including CD90-PerCP, CD34-PE, CD45-Alexa (Santa Cruz, USA) and PBS (negative control), in a black chamber at 4 °C for 30 min. Then, the cells were washed with PBS and fixed in 4% paraformaldehyde, and flow cytometry using the Cellquest system (Becton, Dickinson and Company, USA) was performed to analyse purity. Flow cytometry analysis is described in detail in Additional file 1.
+ Open protocol
+ Expand
5

Characterization of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were cultured in high glucose α-MEM (Gibco, USA), 10% FBS (Gibco, USA), 100 U/ml penicillin and 0.1 mg/ml streptomycin for 1 week, culture medium was replaced twice a week. Cells were collected and counted, then re-suspended with α-MEM, we adjusted the cell density at 1 × 106 cells/ml. Each 0.1 ml sample was incubated with 20 μl of CD73-PE, CD90-FITC, CD34-PE, CD45-PE, CD105-PE (Santa Cruz, USA) at 4 °C for 1 h. Antibody binding was analyzed by flow cytometry (Becton Dickson, USA).
+ Open protocol
+ Expand
6

Characterization of Cryopreserved MNCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BM-MNCs were tested for viability, cellular composition, and phenotypes by using flow cytometry before and after their cryopreservation period. Briefly, 1 × 106 MNCs were suspended in 100 mL Hank's Balanced Salt Solution + 2% FBS and then were incubated with anti-mouse antibodies specific for CD3-FITC, CD8-PE, CD4-PE, CD45-APC, and CD220-PE (1 : 100; Biolegend); CD11b-FITC, CD133-FITC, and CD335-PE (1 : 100; BD Bioscience); CD34-PE (1 : 5; Santa Cruz Biotechnology). Cell viability was assessed by exclusion of 7-amino actinomycin (7-DAA). Stained cells were collected using Gallios Flow Cytometer (Beckman Coulter) and analyzed with Kaluza software (Beckman Coulter). In cryopreserved MNCs treatment group, the frozen MNCs were thawed in 37°C water bath for less than 1 min and washed in DMEM, followed by PBS prior to the assay. To mimic the clinical condition, cell characterization was carried out by selecting specific antibodies which are known to be the closest to human expression [18 (link)–22 (link)].
+ Open protocol
+ Expand
7

Phenotypic Characterization of P3 BMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The concentration of the P3 BMSC suspension was adjusted to 5x106 cells/ml, and the cells were fixed with 4% neutral paraformaldehyde for 30 min. Each EP tube contained 100 μl (approximately 5.0x105 cells) of the suspension. The following antibodies were added to the tubes: CD90-fluorescein isothiocyanate (FITC) as a stem cell marker; CD29-phycoerythrin (PE) and CD44-PE (Serotec Oxford, UK) as mesenchymal lineage markers; and CD11b-PE, CD45-PE, CD106, and CD34-PE (Santa Cruz Biotechnology) as hematopoietic lineage markers. The tube contents were mixed well and incubated at 4°C in the dark for 30 min. Then, a BD FACSCalibur flow cytometer was used to analyze the cells. All antibodies used in the flow cytometry analyses were purchased from BioLegend, unless indicated otherwise.
+ Open protocol
+ Expand
8

Immunophenotypic Characterization of ADSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADSCs and IGF-1-ADSCs were subjected to immunophenotypic characterization. Cultured ADSCs were harvested with 0.25% trypsin and suspended as single cells at a concentration of 5 × 10 5 cells in 500 µl PBS (10 mM, pH 7.4). To verify that cultured cells were MSCs, the cells were analyzed by flow cytometry (FACSCanto; BD Biosciences, Franklin Lakes, NJ, USA) after labeling with CD45-PercP-CY5 (BD Pharmingen™, San Diego, CA, USA), CD34-PE (Santa Cruz Biotechnology, Dallas, TX, USA), CD11b-FITC (Caltag Laboratories, Burlingame, CA, USA), CD29-FITC (BD Pharmingen), and CD90-FITC (Caltag Laboratories). Isotype IgG1 immunoglobulin served as a control. In addition, these cells were cultured in the presence of osteogenic medium [10 nM dexamethasone, 10 mM b-glycerophosphate, 50 µg/ml l-ascorbate 2-phospate, and 10 nM 1a,25-dihydroxyvitamin D 3 (all from BIOMOL Research Laboratories Inc., Plymouth Meeting, PA, USA)] and adipogenic medium [DMEM-low glucose supplemented with 15% fetal calf serum (FCS), 50 U/ml penicillin, 50 mg/ml streptomycin, 5 × 10 -4 M indomethacin, 10 µg/ml human insulin, and 10 -7 M dexamethasone (all from Sigma-Aldrich)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!